Cullin-5 (CUL5) as a potential prognostic marker in a pan-cancer analysis of human tumors

References

• Cui X, Zhang X, Liu M, et al. A pan-cancer analysis of the oncogenic role of staphylococcal nuclease domain-containing protein 1 (SND1) in human tumors. Genomics. 2020;112(6):3958–3967.
   PubMed Web of Science ®Google Scholar
• Sidaway P. Pancreatic cancer: TCGA data reveal a highly heterogeneous disease. Nat Rev Clin Oncol. 2017;14(11):648.
   Google Scholar
• Alexandrov LB, Kim J, Haradhvala NJ, et al. The repertoire of mutational signatures in human cancer. Nature. 2020;578(7793):94–101.
   PubMed Web of Science ®Google Scholar
• Lee YR, Yehia L, Kishikawa T, et al. WWP1 gain-of-function inactivation of PTEN in cancer predisposition. N Engl J Med. 2020;382(22):2103–2116.
   PubMed Web of Science ®Google Scholar
• Burnatowska-Hledin MA, Spielman WS, Smith WL, et al. Expression cloning of an AVP-activated, calcium-mobilizing receptor from rabbit kidney medulla. Am J Physiol. 1995;268(6 Pt 2):F1198–210.
   PubMedGoogle Scholar
• Burnatowska-Hledin M, Zeneberg A, Roulo A, et al. Expression of VACM-1 protein in cultured rat adrenal endothelial cells is linked to the cell cycle. Endothelium-J Endothelial Cell Res. 2001;8(1):49-+.
   Google Scholar
• Kunkler B, Salamango D, DeBruine ZJ, et al. CUL5 is required for thalidomide-dependent inhibition of cellular proliferation. PLoS One. 2018;13(5):e0196760.
   PubMed Web of Science ®Google Scholar
• Zhu Y, Li L, Hou D, et al. MicroRNA-19a regulates the proliferation, migration and invasion of human gastric cancer cells by targeting CUL5. Arch Biochem Biophys. 2019;662:93–100.
   PubMed Web of Science ®Google Scholar
• Gao F, Fan Y, Zhou B, et al. The functions and properties of cullin-5, a potential therapeutic target for cancers. Am J Transl Res. 2020;12(2):618–632.
   PubMed Web of Science ®Google Scholar
• Si L, Jia Y, Lin R, et al. MicroRNA-27a regulates the proliferation, chemosensitivity and invasion of human ovarian cancer cell lines by targeting Cullin 5. Arch Biochem Biophys. 2019;668:9–15.
   PubMed Web of Science ®Google Scholar
• Zhou W, Xu J, Li H, et al. Neddylation E2 UBE2F promotes the survival of lung cancer cells by activating CRL5 to degrade NOXA via the K11 linkage. Clin Cancer Res. 2017;23(4):1104–1116.
   PubMed Web of Science ®Google Scholar
• Zhao G, Gong L, Su D, et al. Cullin5 deficiency promotes small-cell lung cancer metastasis by stabilizing integrin beta1. J Clin Invest. 2019;129(3):972–987.
   PubMed Web of Science ®Google Scholar
• Talamantez-Lyburn S, Brown P, Hondrogiannis N, et al. Gold nanoparticles loaded with cullin-5 DNA increase sensitivity to 17-AAG in cullin-5 deficient breast cancer cells. Int J Pharm. 2019;564:281–292.
   PubMedGoogle Scholar
• Morais-Rodrigues F, Silverio-Machado R, Kato RB, et al. Analysis of the microarray gene expression for breast cancer progression after the application modified logistic regression. Gene. 2020;726:144168.
   PubMed Web of Science ®Google Scholar
• Tang Z, Kang B, Li C, et al. GEPIA2: an enhanced web server for large-scale expression profiling and interactive analysis. Nucleic Acids Res. 2019;47(W1):W556–W560.
   PubMed Web of Science ®Google Scholar
• Szklarczyk D, Franceschini A, Wyder S, et al. STRING v10: protein-protein interaction networks, integrated over the tree of life. Nucleic Acids Res. 2015;43(Database issue):D447–52.
   PubMed Web of Science ®Google Scholar
• Zhou Y, Zhou B, Pache L, et al. Metascape provides a biologist-oriented resource for the analysis of systems-level datasets. Nat Commun. 2019;10(1):1523.
   PubMed Web of Science ®Google Scholar
• Lewis SP, Willis AN, Johnson AE, et al. Mutational analysis of VACM-1/cul5 exons in cancer cell lines. APMIS. 2011;119(7):421–430.
   PubMed Web of Science ®Google Scholar
• Johnson AE, Le IP, Buchwalter A, et al. Estrogen-dependent growth and estrogen receptor (ER)-alpha concentration in T47D breast cancer cells are inhibited by VACM-1, a cul 5 gene. Mol Cell Biochem. 2007;301(1–2):13–20.
   PubMed Web of Science ®Google Scholar
• Leong SPL, Tseng WW. Micrometastatic cancer cells in lymph nodes, bone marrow, and blood: clinical significance and biologic implications. CA Cancer J Clin. 2014;64(3):195–206.
   PubMed Web of Science ®Google Scholar
• DeBerardinis RJ. Tumor microenvironment, metabolism, and immunotherapy. N Engl J Med. 2020;382(9):869–871.
   PubMed Web of Science ®Google Scholar
• Joyce JA, Fearon DT. T cell exclusion, immune privilege, and the tumor microenvironment. Science. 2015;348(6230):74–80.
   PubMed Web of Science ®Google Scholar
• Yang S, Liu T, Nan H, et al. Comprehensive analysis of prognostic immune-related genes in the tumor microenvironment of cutaneous melanoma. J Cell Physiol. 2020;235(2):1025–1035.
   PubMed Web of Science ®Google Scholar
• Zhang S, Sun Y. Cullin RING Ligase 5 (CRL-5): neddylation Activation and Biological Functions. Adv Exp Med Biol. 2020;1217:261–283.
   PubMed Web of Science ®Google Scholar
• Kung -W-W, Ramachandran S, Makukhin N, et al. Structural insights into substrate recognition by the SOCS2 E3 ubiquitin ligase. Nat Commun. 2019;10(1):2534.
   PubMedGoogle Scholar
• Guo H, Shen S, Li Y, et al. Adenovirus oncoprotein E4orf6 triggers Cullin5 neddylation to activate the CLR5 E3 ligase for p53 degradation. Biochem Biophys Res Commun. 2019;516(4):1242–1247.
   PubMed Web of Science ®Google Scholar
• Iwatani Y, Chan DSB, Liu L, et al. HIV-1 Vif-mediated ubiquitination/degradation of APOBEC3G involves four critical lysine residues in its C-terminal domain. Proc Natl Acad Sci U S A. 2009;106(46):19539–19544.
   PubMed Web of Science ®Google Scholar
• Zhao Z, Li Z, Huan C, et al. CAEV Vif Hijacks ElonginB/C, CYPA and Cullin5 to assemble the E3 ubiquitin ligase complex stepwise to degrade oaA3Z2-Z3. Front Microbiol. 2019;10:565.
   PubMed Web of Science ®Google Scholar
• Blondelle J, Biju A, Lange S. The role of Cullin-RING ligases in striated muscle development, function, and disease. Int J Mol Sci. 2020;21(21). DOI:10.3390/ijms21217936
   PubMed Web of Science ®Google Scholar
• Fu L, Cui CP, Zhang LQ. Regulation of Stem Cells by Cullin-RING Ligase. Cullin-Ring Ligases Prote Neddylation: Biol Therap. 2020;1217:79–98.
   Google Scholar
• Samant RS, Clarke PA, Workman P. E3 ubiquitin ligase Cullin-5 modulates multiple molecular and cellular responses to heat shock protein 90 inhibition in human cancer cells. Proc Natl Acad Sci U S A. 2014;111(18):6834–6839.
   PubMed Web of Science ®Google Scholar
• Ma C, Qi Y, Shao L, et al. Downregulation of miR-7 upregulates Cullin 5 (CUL5) to facilitate G1/S transition in human hepatocellular carcinoma cells. IUBMB Life. 2013;65(12):1026–1034.
   PubMed Web of Science ®Google Scholar
• Devor EJ, Schickling BM, Reyes HD, et al. Cullin-5, a ubiquitin ligase scaffold protein, is significantly underexpressed in endometrial adenocarcinomas and is a target of miR-182. Oncol Rep. 2016;35(4):2461–2465.
   PubMed Web of Science ®Google Scholar
• Liu A, Zhang S, Shen Y, et al. Association of mRNA expression levels of Cullin family members with prognosis in breast cancer: an online database analysis. Medicine (Baltimore). 2019;98(31):e16625.
   PubMed Web of Science ®Google Scholar
• Yu X, Yu Y, Liu B, et al. Induction of APOBEC3G ubiquitination and degradation by an HIV-1 Vif-Cul5-SCF complex. Science. 2003;302(5647):1056–1060.
   PubMed Web of Science ®Google Scholar
• Kabir S, Cidado J, Andersen C, et al. The CUL5 ubiquitin ligase complex mediates resistance to CDK9 and MCL1 inhibitors in lung cancer cells. Elife. 2019;8. DOI:10.7554/eLife.44288
   PubMed Web of Science ®Google Scholar